A Systematic Review of the Role of Imaging before Salvage Radiotherapy for Post-prostatectomy Biochemical Recurrence

Hagan, 2004, Comparison of adjuvant versus salvage radiotherapy policies for postprostatectomy radiotherapy, Int J Radiat Oncol Biol Phys, 59, 329, 10.1016/j.ijrobp.2003.11.038

Bolla, 2005, Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911), Lancet, 366, 572, 10.1016/S0140-6736(05)67101-2

Thompson, 2006, Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial, JAMA, 296, 2329, 10.1001/jama.296.19.2329

Thompson, 2009, Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial, J Urol, 181, 956, 10.1016/j.juro.2008.11.032

Freedland, 2003, Defining the ideal cutpoint for determining PSA recurrence after radical prostatectomy. Prostate-specific antigen, Urology, 61, 365, 10.1016/S0090-4295(02)02268-9

Boccon-Gibod, 2004, Management of prostate-specific antigen relapse in prostate cancer: a European Consensus, Int J Clin Pract, 58, 382, 10.1111/j.1368-5031.2004.00184.x

Stephenson, 2007, Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy, J Clin Oncol, 25, 2035, 10.1200/JCO.2006.08.9607

Jhaveri, 1999, Biochemical failure does not predict overall survival after radical prostatectomy for localized prostate cancer: 10-year results, Urology, 54, 884, 10.1016/S0090-4295(99)00252-6

Pound, 1999, Natural history of progression after PSA elevation following radical prostatectomy, JAMA, 281, 1642, 10.1001/jama.281.17.1591

Stephenson, 2004, Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy, JAMA, 291, 1325, 10.1001/jama.291.11.1325

Hayes, 2005, Parameters for treatment decisions for salvage radiation therapy, J Clin Oncol, 23, 8204, 10.1200/JCO.2005.03.1575

Oesterling, 1987, Long-term autopsy findings following radical prostatectomy, Urology, 29, 584, 10.1016/0090-4295(87)90096-3

Scattoni, 2003, Multiple vesico-urethral biopsies following radical prostatectomy: the predictive roles of TRUS, DRE, PSA and the pathological stage, Eur Urol, 44, 407, 10.1016/S0302-2838(03)00320-8

Saleem, 1998, Factors predicting cancer detection in biopsy of the prostatic fossa after radical prostatectomy, Urology, 51, 283, 10.1016/S0090-4295(97)00509-8

Schild, 1996, The use of radiotherapy for patients with isolated elevation of serum prostate specific antigen following radical prostatectomy, J Urol, 156, 1725, 10.1016/S0022-5347(01)65492-2

Forman, 1998, Therapeutic radiation in patients with a rising post-prostatectomy PSA level, Oncology (Williston Park), 12, 33

Swanson, 2007, Predominant treatment failure in postprostatectomy patients is local: analysis of patterns of treatment failure in SWOG 8794, J Clin Oncol, 25, 2225, 10.1200/JCO.2006.09.6495

King, 2008, Improved outcomes with higher doses for salvage radiotherapy after prostatectomy, Int J Radiat Oncol Biol Phys, 71, 23, 10.1016/j.ijrobp.2007.09.047

Leventis, 2001, Local recurrence after radical prostatectomy. Correlation of US features with prostatic fossa biopsy findings, Radiology, 219, 432, 10.1148/radiology.219.2.r01ma20432

Scattoni, 2002, Biopsy of the vesico-urethral anastomosis after radical prostatectomy: when and how, Eur Urol, 38, 89, 10.1016/S1569-9056(02)00062-3

Scattoni, 2004, Diagnosis of local recurrence after radical prostatectomy, BJU Int, 93, 680, 10.1111/j.1464-410X.2003.04692.x

Cher, 1998, Limited role of radionuclide bone scintigraphy in patients with prostate specific antigen elevations after radical prostatectomy, J Urol, 160, 1387, 10.1016/S0022-5347(01)62545-X

Okotie, 2004, Predictors of metastatic disease in men with biochemical failure following radical prostatectomy, J Urol, 171, 2260, 10.1097/01.ju.0000127734.01845.99

Kane, 2003, Limited value of bone scintigraphy and computed tomography in assessing biochemical failure after radical prostatectomy, Urology, 61, 607, 10.1016/S0090-4295(02)02411-1

Gomez, 2004, Radionuclide bone scintigraphy in patients with biochemical recurrence after radical prostatectomy: when is it indicated, BJU Int, 94, 299, 10.1111/j.1464-410X.2004.04927.x

Dotan, 2005, Pattern of prostate-specific antigen (PSA) failure dictates the probability of a positive bone scan in patients with an increasing PSA after radical prostatectomy, J Clin Oncol, 23, 1962, 10.1200/JCO.2005.06.058

Oyen, 1994, Lymph node staging of localised prostatic carcinoma with CT and CT-guided fine needle aspiration biopsy: prospective study of 285 patients, Radiology, 190, 315, 10.1148/radiology.190.2.8284375

Johnstone, 1997, Yield of imaging and scintigraphy assessing biochemical failure in prostate cancer patients, Urol Oncol, 3, 108, 10.1016/S1078-1439(98)00007-6

Kramer, 1997, Sensitivity of computed tomography in detecting local recurrence of prostatic carcinoma following radical prostatectomy, Br J Radiol, 70, 995, 10.1259/bjr.70.838.9404201

Sella, 2004, Suspected local recurrence after radical prostatectomy: endorectal coil MR imaging, Radiology, 231, 379, 10.1148/radiol.2312030011

Michalski, 2009, Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer, Int J Radiat Oncol Biol Phys

Miralbell, 2007, Endorectal MRI assessment of local relapse after surgery for prostate cancer: a model to define treatment field guidelines for adjuvant radiotherapy in patients at high risk for local failure, Int J Radiat Oncol Biol Phys, 67, 356, 10.1016/j.ijrobp.2006.08.079

Alonzi, 2007, Dynamic contrast enhanced MRI in prostate cancer, Eur J Radiol, 63, 335, 10.1016/j.ejrad.2007.06.028

Haider, 2008, Dynamic contrast-enhanced magnetic resonance imaging for localisation of recurrent prostate cancer after external beam radiotherapy, Int J Radiat Oncol Biol Phys, 70, 425, 10.1016/j.ijrobp.2007.06.029

Jackson, 2009, Dynamic contrast-enhanced MRI for prostate cancer localization, Br J Radiol, 82, 148, 10.1259/bjr/89518905

Cheikh, 2009, Evaluation of T2-weighted and dynamic contrast-enhanced MRI in localising prostate cancer before repeat biopsy, Eur Radiol, 19, 770, 10.1007/s00330-008-1190-8

Sciarra, 2008, Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer, Eur Urol, 54, 589, 10.1016/j.eururo.2007.12.034

Gibbs, 2001, Comparison of quantitative T2 mapping and diffusion-weighted imaging in the normal and pathologic prostate, Magn Reson Med, 46, 1054, 10.1002/mrm.1298

Haider, 2007, Combined T2-weighted and diffusion-weighted MRI for localisation of prostate cancer, Am J Radiol, 189, 323

Harisinghani, 2003, Noninvasive detection of clinically occult lymph-node metastases in prostate cancer, N Engl J Med, 348, 2491, 10.1056/NEJMoa022749

Brush, 2001, Positron emission tomography in urological malignancy, Curr Opin Urol, 11, 175, 10.1097/00042307-200103000-00008

Rinnab, 2007, Evaluation of [11C]-choline positron-emission/computed tomography in patients with increasing prostate-specific antigen levels after primary treatment for prostate cancer, BJU Int, 100, 786, 10.1111/j.1464-410X.2007.07083.x

Scattoni, 2007, Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy, Eur Urol, 52, 423, 10.1016/j.eururo.2007.03.032

Schilling, 2008, Histological verification of 11C-choline-positron emission/computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer, BJU Int, 102, 446, 10.1111/j.1464-410X.2008.07592.x

Pelosi, 2008, Role of whole-body 18F-choline PET/CT in disease detection in patients with biochemical relapse after radical treatment for prostate cancer, Radiol Med, 113, 895, 10.1007/s11547-008-0263-8

Cimitan, 2006, [18F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients, Eur J Nucl Med Mol Imaging, 33, 1387, 10.1007/s00259-006-0150-2

Oyama, 2002, 11C-acetate PET imaging of prostate cancer, J Nucl Med, 43, 181

Vees, 2007, 18F-choline and/or 11C-acetate positron emission tomography: detection of residual or progressive subclinical disease at very low prostate-specific antigen values (<1 ng/mL) after radical prostatectomy, BJU Int, 99, 1415, 10.1111/j.1464-410X.2007.06772.x

Hinkle, 1998, Multicenter radioimmunoscintigraphic evaluation of patients with prostate carcinoma using indium-111 capromab pendetide, Cancer, 83, 739, 10.1002/(SICI)1097-0142(19980815)83:4<739::AID-CNCR16>3.0.CO;2-T

Wilkinson, 2004, The role of 111indium-capromab pendetide imaging for assessing biochemical failure after radical prostatectomy, J Urol, 172, 133, 10.1097/01.ju.0000132138.02846.08

Koontz, 2008, Use of local (111)in-capromab pendetide scan results to predict outcome after salvage radiotherapy for prostate cancer, Int J Radiat Oncol Biol Phys, 71, 358, 10.1016/j.ijrobp.2007.10.020

Raj, 2002, Clinical utility of indium 111-capromab pendetide immunoscintigraphy in the detection of early recurrent prostate cancer after radical prostatectomy, Cancer, 94, 987, 10.1002/cncr.10337

Petronis, 1998, Indium-111 capromab pendetide (Prostascint) imaging to detect recurrent and metastatic prostate cancer, Clin Nucl Med, 23, 672, 10.1097/00003072-199810000-00005

Elgamal, 1998, Prostascint scan may enhance identification of prostate cancer recurrences after prostatectomy, radiation or hormone therapy: analysis of 136 scans of 100 patients, Prostate, 37, 261, 10.1002/(SICI)1097-0045(19981201)37:4<261::AID-PROS8>3.0.CO;2-#

Nagda, 2007, Long-term follow-up of 111In-capromab pendetide (ProstaScint) scan as pretreatment assessment in patients who undergo salvage radiotherapy for rising prostate-specific antigen after radical prostatectomy for prostate cancer, Int J Radiat Oncol Biol Phys, 67, 834, 10.1016/j.ijrobp.2006.09.026